Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Tax Provisions (2018 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Tax Provisions for 8 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions rose 774.04% year-over-year to $5.3 million, compared with a TTM value of $4.4 million through Dec 2025, up 6.81%, and an annual FY2025 reading of $4.4 million, up 6.81% over the prior year.
  • Tax Provisions was $5.3 million for Q4 2025 at Tandem Diabetes Care, up from -$4.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $8.5 million in Q1 2025 and bottomed at -$5.3 million in Q2 2025.
  • Average Tax Provisions over 5 years is $649150.0, with a median of $312000.0 recorded in 2021.
  • Peak annual rise in Tax Provisions hit 3352.46% in 2022, while the deepest fall reached 1600.0% in 2022.
  • Year by year, Tax Provisions stood at $337000.0 in 2021, then tumbled by 176.56% to -$258000.0 in 2022, then tumbled by 420.54% to -$1.3 million in 2023, then surged by 41.77% to -$782000.0 in 2024, then skyrocketed by 774.04% to $5.3 million in 2025.
  • Business Quant data shows Tax Provisions for TNDM at $5.3 million in Q4 2025, -$4.0 million in Q3 2025, and -$5.3 million in Q2 2025.